DOTmed Home MRI Oncology Ultrasound Molecular Imaging X-Ray Cardiology Health IT Business Affairs
News Home Parts & Service Operating Room CT Women's Health Proton Therapy Endoscopy HTMs Mobile Imaging
SEARCH
当前地点:
>
> This Story


注册记数器 to rate this News Story
Forward Printable StoryPrint Comment

 

 

Molecular Imaging Homepage

Tc-99m generator production resumes in Australia Follows month and a half shutdown due to conveyor belt issue

Cerveau Technologies to expand production network for research on novel tau imaging agent Understanding Alzheimer's with [18F]MK-6240

Sotera Health's Nordion closes sale of medical isotopes business to BWX Technologies About 150 employees will be transferred in the deal

GE Healthcare, Lantheus start second Flurpiridaz phase 3 clinical trial Evaluating PET agent's ability to detect CAD

New technologies to help expand PET/CT imaging in emerging markets Insights from Rick Rippin, sales director for ABT Molecular Imaging

RadioMedix and ITM greenlight Ge-68/Ga-68 generator production at new Texas facility Reducing global shortage of Ge-68/Ga-68 generators

First order of NorthStar's RadioGenix System in the books Comes alongside FDA clearance of its Wisconsin facility

SNMMI and others urge Congress to approve $20 million for U.S. supply of Mo-99 Funding would be provided for NNSA's medical isotope program

Low-risk patients subject to costly, unnecessary breast imaging, says study Ranges from $2,000 to $8,000, creates high-deductible burdens

ITM enters North American partnerships to establish stable n.c.a.-Lutetium-177 supply Enhance use and supply for targeted radionuclide therapy

A new role for PET in interventional procedures

By Farhad Daghighian
From the June 2018 issue of DOTmed HealthCare Business News magazine

It’s well known that positron emission tomography (PET) imaging provides physiologic, molecular and functional information on tumors and various organs.

One way to improve biopsy results is to leverage the physiologic (metabolic or immunologic) information provided by PET imaging to effectively target and sample tissues, especially when X-ray CT or ultrasound does not identify the abnormality.
Story Continues Below Advertisement

Servicing GE Nuclear Medicine equipment with OEM trained engineers

We offer full service contracts, PM contracts, rapid response, time and material,camera relocation. Nuclear medicine equipment service provider since 1975. Click or call now for more information 800 96 NUMED


Cost and logistic issues hinder the wide use of PET in interventional settings. In order to make interventional PET economically viable, it should be portable between the radiology and interventional rooms. While in a radiology department it will be placed parallel to a CT scanner for routine PET/CT scanning. When needed, it will be moved to surgery rooms, ER, ICU, and radiotherapy suites.

Prescient Imaging LLC has developed a low-cost, portable PET scanner (P-Arm) that can make PET imaging accessible for interventional procedures. P-Arm has wheels and is a portable PET scanner, similar to that of X-ray C-arm. One set of its detectors moves under the patient, while another set is placed above the patient for complete 360 degree views while the patient is within the scanner.

18F-FDG PET can identify the most metabolically active portion of a tumor or abnormality, and distinguish between biologically aggressive and non-aggressive regions of malignant masses, thus providing a greater chance to effectively sample suspicious tissues and obtain a higher quality biopsy sample (higher tumor content) suitable for molecular diagnosis. Other radiotracers, with different biological properties (such as monoclonal antibodies), have shown promise for advancing precision medicine by detecting occult lesions and enabling their targeting with biopsy.

Physicians at Rambam Health Center in Israel retrospectively assessed data from 311 consecutive patients with lung nodules who underwent 18F-FDG PET/CT and CT-guided FNA within an interval of less than 30 days. They concluded that anatomy- and metabolism-based fine-needle-aspiration guidance using information provided by both 18F-FDG PET and CT may improve the accuracy of histologic examinations, decrease the rate of false negative results, and thus increase the probability of achieving a definitive diagnosis.

PET is being increasingly used to aid interventional procedures at major academic centers. For example, Dr. Stephen B. Solomon used a PET/CT scanner that was installed in the Center for Image-Guided Intervention at Memorial Sloan Kettering Cancer Center to image liver tumors in more than 300 patients, before and after radioablation, in order to detect any untreated region of the tumor and complete the therapy. Also, in a recent pilot study they have demonstrated the feasibility of performing delayed PET image-guided biopsy using 89Zr anti-PSMA or trastuzumab radiotracers without tracer reinjection. This is an efficient method to optimize workflow, since 89Zr half-life is 79 hours.
  Pages: 1 - 2 >>

Molecular Imaging Homepage


You Must Be Logged In To Post A Comment

做广告
提升您的品牌知名度
拍卖+私人销售
获得最好的价格
买设备/配件
找到最低价格
每日新闻
阅读最新信息
目录
浏览所有的DOTmed用户
DOTmed上的伦理
查看我们的伦理计划
金子分开供营商节目
接收PH要求
金子服务经销商节目
接收请求
提供保健服务者
查看所有的HCP(简称医疗保健提供商)的工具
工作/训练
查找/申请工作
Parts Hunter +EasyPay
获取配件报价
最近证明
查看最近通过认证的用户
最近额定
查看最近通过认证的用户
出租中央
租用设备优惠
卖设备/配件
得到最划算
服务技术员论坛
查找帮助和建议
简单的征求建议书
获取设备报价
真正商业展览
查找对设备的服务
对这个站点的通入和用途是受期限和条件我们支配 法律公告 & 保密性通知
物产和业主对 DOTmed.com,公司 Copyright ©2001-2018 DOTmed.com, Inc.
版权所有